Stella Elkabes, PhD

Neurological Surgery University of Medicine and Dentistry of New Jersey-Newark 
PMCA2, spinal cord, multiple sclerosis
"Stella Elkabes"
Mean distance: 15.38 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Acioglu C, Mirabelli E, Baykal AT, et al. (2016) Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: direct versus astrocyte-mediated mechanisms. Brain, Behavior, and Immunity
Fragale JE, Khariv V, Gregor DM, et al. (2015) Dysfunction in Amygdala-Prefrontal Plasticity and Extinction-Resistant Avoidance: A model for anxiety disorder vulnerability. Experimental Neurology
Ersen A, Elkabes S, Freedman DS, et al. (2015) Chronic tissue response to untethered microelectrode implants in the rat brain and spinal cord. Journal of Neural Engineering. 12: 016019
Li Y, Korgaonkar AA, Swietek B, et al. (2015) Toll-like receptor 4 enhancement of non-NMDA synaptic currents increases dentate excitability after brain injury. Neurobiology of Disease. 74: 240-53
Heiman A, Pallottie A, Heary RF, et al. (2014) Toll-like receptors in central nervous system injury and disease: a focus on the spinal cord. Brain, Behavior, and Immunity. 42: 232-45
David BT, Sampath S, Dong W, et al. (2014) A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury. Journal of Neurotrauma. 31: 1800-6
Elkabes S, Nicot AB. (2014) Sex steroids and neuroprotection in spinal cord injury: a review of preclinical investigations. Experimental Neurology. 259: 28-37
Mandal M, Donnelly R, Elkabes S, et al. (2013) Maternal immune stimulation during pregnancy shapes the immunological phenotype of offspring. Brain, Behavior, and Immunity. 33: 33-45
Khariv V, Pang K, Servatius RJ, et al. (2013) Toll-like receptor 9 deficiency impacts sensory and motor behaviors. Brain, Behavior, and Immunity. 32: 164-72
David BT, Ratnayake A, Amarante MA, et al. (2013) A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury. Neurobiology of Disease. 54: 194-205
See more...